E
EMMAC Life Sciences
Vertically integrated European medical cannabis and wellness products
About EMMAC Life Sciences
Curaleaf Medical is the scientific arm of Curaleaf International. Our team focuses on advancing our understanding of the potential therapeutic value of cannabis used for medicinal purposes (also known as medical marajuana) and how we can develop products that meet the needs of people all across Europe.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- London, United Kingdom
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Latest news
Press, funding announcements and product moves mentioning EMMAC Life Sciences.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Material V
Series B and later1 investor entered at this stage
- MVMaterial V
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about EMMAC Life Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EMMAC Life Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.